Cannabis & Veteran Conditions — Evidence Scorecard

This page summarizes what peer-reviewed research actually shows for cannabis across the conditions most commonly seen in U.S. veterans. We rate evidence honestly — where the science is uncertain, we say so. Where it is settled, we say that too. No false hope. No dismissive skepticism.

Evidence Scorecard

Condition	Evidence	Key Finding
Chronic Neuropathic Pain	Moderate Evidence	NNT ~3.4 in some reviews. Modest but real benefit. Most trials studied pharmaceutical cannabinoids, not plant cannabis.
PTSD Nightmares (Nabilone)	Moderate Evidence	Jetly 2015 RCT in 10 Canadian military showed reduced CAPS nightmare scores. Very small sample.
PTSD (Plant Cannabis)	Low Evidence	Only completed RCT (Bonn-Miller 2021) found no significant advantage over placebo. Observational studies suggest benefit but have severe limitations.
Musculoskeletal Pain	Low Evidence	Most common veteran pain type, but very limited cannabis-specific evidence. Gap between what's studied and what veterans have.
Anxiety (CBD-Specific)	Low-Moderate Evidence	CBD at 300-600mg shows anxiolytic effect in small trials. Narrow therapeutic window. Most commercial products use much lower doses.
Anxiety (THC-Containing)	Low Evidence — biphasic: low doses anxiolytic, high doses anxiogenic	Dose-dependent. High doses can worsen anxiety and trigger panic in naive users.
Traumatic Brain Injury	Low Evidence — preclinical only	Endocannabinoid system plays role in brain repair in animal models. Human evidence sparse. Cannabis adverse effects overlap with TBI symptoms.
Military Sexual Trauma	No Evidence	No clinical trials. Cross-sectional data only shows association with cannabis use among MST survivors.
Gulf War Illness	Low Evidence — emerging	2026 OEA trial (not cannabis itself) improved mood/fatigue. Preclinical endocannabinoid deficiency research. No FDA-approved treatment.
Agent Orange Conditions	No Evidence	Virtually no direct research. Complete gap.
Cannabis Use Disorder	Evidence Against — CUD itself is a harm	9.2% veteran lifetime prevalence. 72% CUD-PTSD comorbidity. VA offers evidence-based treatment.
Suicide	Evidence Against — individual-level studies show increased risk	Ecological claims that "cannabis prevents suicide" misuse the evidence. Individual studies show CUD associated with elevated suicidality.

How to Read These Ratings

• High evidence: Large, well-designed RCTs or comprehensive systematic reviews with low risk of bias
• Moderate evidence: Smaller RCTs, well-designed observational studies, reviews with some limitations
• Low-moderate evidence: Observational studies with limited controls, ecological analyses, small-sample RCTs
• Low evidence: Case series, open-label trials, retrospective reviews, preclinical data only
• No evidence: No published clinical trials or systematic reviews for the specific condition/population
• Evidence against: Research consistently shows harm or failure to demonstrate benefit

Read our full evidence framework.

What This Means for Veterans

If you are considering cannabis for a specific condition, the evidence base may or may not support your decision. Evidence is not the only relevant consideration — your personal experience, symptom severity, existing treatments that have or have not worked, and the risk/benefit calculation for your situation also matter. But the evidence should be part of your reasoning, and it should be reported honestly. Cannabis is not a miracle. It is not a moral failure. It is a plant with modest clinical evidence for specific indications, meaningful risks for veterans on multiple medications, and a particular vulnerability to cannabis use disorder among those with comorbid PTSD.

Our detailed condition pages cover each area in depth, with full citations to primary research:

Related Reading

• Critical Drug Interactions
• Our Methodology
• Evidence Framework